Abiopharma

News list

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Full text

News bot Oct. 18, 2025, 5:36 p.m.
🌍 Genmab (GMAB) - Form 6-K Filing

Filing Date: 2022-06-23

Accepted: 2022-06-23 12:02:29

Event Type: Clinical Trial Update

Event Details:

Reason for the notification a) Positionstatus Member of the Board of Directors b) Initial notificationAmendment Initial notification 3. Details of the person discharging managerial responsibilities person closely associated a) Name Anders Gersel Pedersen2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Genmab AS b) LEI-code 529900MTJPDPE4MHJ122 4.
💼 Business Developments:
- ✅ Partnership/Collaboration
- ❌ Acquisition Activity: Not reported
- ❌ Licensing Agreement: Not reported
- ❌ Regulatory Milestone: Not reported
- ❌ Leadership Updates: Not reported
📞 Contact Information:
- Email: mmp@genmab.com